Barclays raised the firm's price target on Slide Insurance to $31 from $29 and keeps an Overweight rating on the shares. The company's gross written premiums grow 49% year-over-year as both lower expenses and more benign losses drive a combined ratio beat, the analyst tells investors in a research note.
